V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004978 | 280003293 | 1.6 | 85 | Palliative (P) | 2015-08-05 | 2015-08-05 | DOCETAXEL + GEMCITABINE | N | N | 280028292 | OXALIPLATIN + MDG |
| 280004979 | 280007702 | 1.8 | null | Palliative (P) | 2014-09-18 | 2014-09-18 | FLUOROURACIL + MITOMYCIN + RT | null | null | 280028295 | ECX |
| 280004980 | 280007702 | 1.5 | 51.5 | Palliative (P) | 2015-02-21 | 2015-02-21 | Dacarbazine | 02 | N | 280028295 | CAPECITABINE + STREPTOZOCIN |
| 280004981 | 280003294 | 0 | null | null | null | 2016-04-23 | Pazopanib | N | N | 280028299 | CARBOPLATIN + PEMETREXED |
| 280004982 | 280007703 | null | 93.4 | Palliative (P) | 2014-04-16 | 2014-05-18 | Carbo F | N | N | 280028300 | CAPECITABINE + OXALIPLATIN |
| 280004983 | 280003295 | 0 | 78 | Neo-adjuvant (N) | 2013-07-30 | 2013-08-06 | Oxaliplatin + Modified de Gramont | 2 | N | 280028302 | DACARBAZINE |
| 280004984 | 280003295 | 1.73 | 88 | Palliative (P) | 2015-04-11 | 2015-04-13 | ECX | N | N | 280028302 | LANREOTIDE |
| 280004985 | 280003296 | 1.84 | 87.3 | Palliative (P) | 2016-09-10 | 2016-09-16 | Mitomycin Intravesical | 02 | N | 280028308 | CAPECITABINE |
| 280004986 | 280007705 | 1.71 | 71.2 | Palliative (P) | 2017-05-16 | 2017-05-16 | Cisplatin + Pemetrexed | N | N | 280028314 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280004987 | 280007705 | 1.68 | 69 | Disease modification (D) | 2017-08-07 | 2017-08-08 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 280028314 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280004988 | 280003297 | 1.86 | 62.1 | Palliative (P) | 2017-02-12 | 2017-02-14 | Cisplatin + Etoposide (3 day) | null | null | 280028320 | FLUOROURACIL |
| 280004989 | 280003298 | 1.79 | 58 | Palliative (P) | 2014-02-28 | 2014-03-14 | Capecitabine | N | N | 280028322 | OCTREOTIDE |
| 280004990 | 280003298 | 1.68 | 90.5 | Adjuvant (A) | 2017-06-12 | 2017-06-17 | Enzalutamide | 02 | null | 280028322 | BENDAMUSTINE |
| 280004991 | 280009932 | 1.55 | 82 | Palliative (P) | 2013-07-03 | 2013-07-24 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028326 | ECX |
| 280004992 | 280003299 | 1.78 | 70.5 | Palliative (P) | 2018-02-17 | 2018-02-17 | CARBOPLATIN + PACLITAXEL + RT | N | N | 280028327 | GEMCARBO |
| 280004993 | 280003300 | 1.72 | 84 | Palliative (P) | 2016-08-24 | 2016-08-24 | TCF | N | N | 280028330 | FLUOROURACIL + MITOMYCIN |
| 280004994 | 280003301 | 1.67 | 69.95 | null | 2015-05-23 | 2015-05-23 | Docetaxel + Gemcitabine with GCSF | N | N | 280028334 | DACARBAZINE |
| 280004995 | 280003301 | 1.65 | 60 | Adjuvant (A) | 2015-12-28 | 2016-01-21 | Docetaxel + Gemcitabine (prior RT) | Y | Y | 280028334 | MITOMYCIN INTRAVESICULAR |
| 280004996 | 280003301 | 1.72 | 59.9 | Neo-adjuvant (N) | 2016-04-29 | 2016-04-30 | Capecitabine + Oxaliplatin 21day | 2 | null | 280028334 | BEVACIZUMAB |
| 280004997 | 280003302 | 1.84 | null | Palliative (P) | 2015-08-12 | 2015-08-18 | Pemetrexed | 02 | null | 280028337 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280004998 | 280003303 | 1.73 | 2 | Palliative (P) | 2015-10-06 | 2015-10-09 | Oxaliplatin + Modified de Gramont | 02 | N | 280028341 | CAPECITABINE + OXALIPLATIN |
| 280004999 | 280003304 | null | 78.8 | Palliative (P) | 2013-06-14 | 2013-06-21 | VIDE | N | N | 280028342 | OXALIPLATIN + MDG |
| 280005000 | 280003305 | 1.69 | 52.6 | Adjuvant (A) | 2017-03-14 | 2017-03-17 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 280028344 | CAPECITABINE + OXALIPLATIN |
| 280005001 | 280003305 | 1.71 | 91.6 | Neo-adjuvant (N) | 2015-10-14 | 2015-11-02 | Capecitabine | 02 | Y | 280028344 | CAPECITABINE + STREPTOZOCIN |
| 280005002 | 280003306 | 1.67 | 91.6 | Adjuvant (A) | 2014-09-21 | 2014-09-22 | CARBOPLATIN + GEMCITABINE | N | N | 280028346 | MITOMYCIN INTRAVESICULAR |
| 280005003 | 280003307 | 1.62 | 93.8 | Palliative (P) | 2016-05-22 | 2016-06-14 | Cisplatin + Pemetrexed | 2 | N | 280028347 | CAPECITABINE + OXALIPLATIN |
| 280005004 | 280003308 | 1.82 | 82 | Palliative (P) | 2013-01-22 | 2013-02-06 | Epirubicin | 01 | N | 280028348 | CAPECITABINE + GEMCITABINE |
| 280005005 | 280003309 | 0 | 56.5 | Palliative (P) | 2016-12-09 | 2016-12-17 | Doxorubicin + Olaratumab | N | N | 280028349 | LANREOTIDE |
| 280005006 | 280007709 | 1.5 | 58.6 | Not known (9) | 2017-03-04 | 2017-03-26 | KESTREL Trial | 1 | N | 280028351 | CARBOPLATIN + PEMETREXED |
| 280005007 | 280003310 | 1.88 | 89.8 | Palliative (P) | 2017-04-13 | 2017-04-19 | Cisplatin + Etoposide (3 day) | null | null | 280028353 | CAPECITABINE + OXALIPLATIN |
| 280005008 | 280007710 | 1.6 | null | null | 2015-12-29 | 2015-12-31 | Gemcitabine weekly | N | N | 280028355 | CISPLATIN + PEMETREXED |
| 280005009 | 280007710 | 1.85 | 87.9 | Palliative (P) | 2018-06-05 | 2018-06-16 | Cisplatin + Vinorelbine (IV) | 02 | N | 280028355 | OCTREOTIDE |
| 280005010 | 280007710 | null | null | Palliative (P) | 2015-02-01 | 2015-02-18 | Cetuximab + CISPLATIN | N | N | 280028355 | CAPECITABINE + OXALIPLATIN |
| 280005011 | 280003311 | 1.63 | 91 | Palliative (P) | null | 2015-11-03 | Docetaxel 75mg/m2 (21 day) | N | N | 280028359 | RITUXIMAB |
| 280005012 | 280003311 | 1.7 | null | Palliative (P) | 2016-05-31 | 2016-06-05 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 280028359 | IPILIMUMAB + NIVOLUMAB |
| 280005013 | 280003311 | null | 70.4 | Palliative (P) | 2017-08-13 | 2017-08-14 | IPILIMUMAB + NIVOLUMAB | N | null | 280028359 | CAPECITABINE + CISPLATIN |
| 280005014 | 280003311 | 1.72 | 67.2 | Curative (C) | 2015-03-15 | 2015-04-05 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | N | N | 280028359 | CISPLATIN + VINORELBINE |
| 280005015 | 280003311 | null | 62.6 | Palliative (P) | 2013-11-15 | 2013-12-15 | Capecitabine + Cisplatin + RT | N | null | 280028359 | DABRAFENIB |
| 280005016 | 280003311 | null | 100.2 | null | null | 2013-04-11 | Cisplatin + Pemetrexed | null | null | 280028359 | BEP |
| 280005017 | 280003312 | 1.58 | null | Palliative (P) | null | 2014-05-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 280028370 | FCIST |
| 280005018 | 280003312 | 1 | 70.8 | Adjuvant (A) | 2017-12-02 | 2017-12-08 | Capecitabine | 02 | null | 280028370 | ECX |
| 280005019 | 280003312 | 1.78 | 108.3 | Palliative (P) | 2014-06-16 | 2014-07-06 | EP 1 2 or 3 day | N | N | 280028370 | CAPECITABINE + CISPLATIN |
| 280005020 | 280003312 | 1.56 | 86.3 | Palliative (P) | 2015-01-19 | 2015-02-15 | EW EuroEwing 2012 Arm A VIDE | Y | Y | 280028370 | CAPECITABINE + CISPLATIN |
| 280005021 | 280003312 | 1.52 | null | Palliative (P) | 2016-06-10 | 2016-06-18 | DE-ESCALATE TRIAL | 2 | N | 280028370 | CAPECITABINE + OXALIPLATIN |
| 280005022 | 280003312 | null | 56.9 | Palliative (P) | null | 2013-06-14 | Docetaxel | N | null | 280028370 | ECX |
| 280005023 | 280003313 | 1.68 | 61 | Palliative (P) | 2014-08-17 | 2014-08-21 | PEMBROLIZUMAB | 2 | N | 280028379 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 280005024 | 280003313 | 1.56 | 57.6 | Palliative (P) | 2018-05-26 | 2018-05-26 | Capecitabine + Oxaliplatin 21day | Y | N | 280028379 | GEMCARBO |
| 280005025 | 280003314 | 1.74 | 71.75 | Disease modification (D) | 2016-09-09 | 2016-09-17 | IMATINIB | N | N | 280028386 | OCTREOTIDE |
| 280005026 | 280003314 | 1.71 | 85.4 | Palliative (P) | 2017-04-01 | 2017-04-01 | Bortezomib + Cyclophos + Dex | 02 | N | 280028386 | GEMCITABINE |
| 280005027 | 280003315 | 1.83 | null | null | 2017-12-16 | 2017-12-16 | Abiraterone | N | N | 280028396 | CAPECITABINE |